Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial
F1000Research · 12.08.2024 · 13 · 9
DOI: 10.12688/f1000research.139568.3 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift F1000Research, online erschienen am 12.08.2024. Verfasst von Mayank Rai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Datta Meghe Institute of Higher Education & Research, Wardha, Maharashtra, India. Hauptthemen laut MEDLINE: Plant Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Not any.
Abstract (Originalsprache)
Background
In ayurveda, sciatica can be correlated to ‘ Grudhrasi’ under Vata Nanatmaja-Vyadhi (neurological disorders caused by Vata , one of the bodily humour). In this mainly bodily humours vata and kapha are vitiating producing symptoms like piercing pain, stiffness, twitching, numbness and pain radiating from lumbosacral region to lower limb up to the foot. Therapeutic plan includes stabilizing and bringing back the vitiated vata and kapha humours to equilibrium. The prevalence of sciatica varies considerably ranging from 3.8% in the working population to 7.9% in the nonworking population.
Aim
Comparative evaluation of efficacy of Rasonapinda and Trayodashang guggul as an adjuvant to katibasti (oil pooling therapy) in the management of Grudhrasi (Sciatica).
Objectives
To assess the efficacy of Rasonapinda as an adjuvant to katibasti in subjective and objective parameters of Grudhrasi (Sciatica). To assess the efficacy of Trayodashang guggul as an adjuvant to katibasti in subjective and objective parameters of Grudhrasi (Sciatica). To compare the efficacy of Rasonapinda and Trayodashang guggul as an adjuvant to katibasti in subjective and objective parameters. Standardisation of Rasonapinda (modified formvati).
Methods
In this study, a total of 60 patients will be enrolled and divided equally into two groups. In group A, Trayodashang Guggul 500 mg twice a day after meal with warm water for 30 days adjuvant with katibasti for the initial 7 days will be given. In group B, Rasonapinda 500 mg twice a day after meal with warm water adjuvant with katibasti for the initial 7 days will be given for 30 days.
Result
The result will be assessed on baseline of subjective and objective parameters and data will be compared after treatment.
Conclusions
It will be based on observations and results obtained.
Trial registration
CTRI No. - CTRI/2022/12/048534 Dated – 27/12/2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Datta Meghe Institute of Higher Education & Research, Wardha, Maharashtra, India.
ORCID-Profile: Mayank Rai, Sadhana Misar, Reeya Gamne
Förderung
- Not any
Zitieren
APA
Rai, M., Misar, S., & Gamne, R. (2024). Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial. F1000Research, 13, 9. https://doi.org/10.12688/f1000research.139568.3
Vancouver
Rai M, Misar S, Gamne R. Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial. F1000Research. 2024;13:9. doi:10.12688/f1000research.139568.3
BibTeX
@article{Rai2024,
author = {Rai, Mayank and Misar, Sadhana and Gamne, Reeya},
title = {Comparative evaluation of efficacy of Trayodashang Guggul versus Rasona Pinda as an adjuvant with Katibasti in the management of Grudhrasi (Sciatica): A randomized controlled trial},
journal = {F1000Research},
year = {2024},
volume = {13},
pages = {9},
doi = {10.12688/f1000research.139568.3}
}
EUVIMED